Outcomes of CAG regimen for refractory biphenotypic acute leukemia patients. [electronic resource]
Producer: 20091211Description: 178-81 p. digitalISSN:- 1001-9294
- Aclarubicin -- administration & dosage
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cytarabine -- administration & dosage
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Leukemia, Biphenotypic, Acute -- drug therapy
- Male
- Remission Induction
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.